The 61% Growth That Masks a Slower, Margin-Squeezed Organic Story
Omnitech's Q1 reported 61.5% YoY revenue growth and a 30.4% EBITDA margin, but the comparison is inflated by a weak prior-year base. Quarter-on-quarter momentum is softer: revenue up 12%, PAT up just 1.4%. The market's -14% selloff reflects justified skepticism about organic profitability.
+61.5%
Revenue ₹166.7 Cr | PAT ₹29.7 Cr
+12.1% rev | +1.4% PAT
Margin compression ~90 bps
-14.41%
₹732.6 → ₹578.35
The headline is a distraction. Omnitech's 61.5% YoY revenue growth and 468.7% PAT surge look exceptional on paper, but both metrics are inflated by a deeply depressed prior-year base: Q1 FY26 coincided with the Chhapara facility ramp-up and heavy pre-emptive investment. The real earnings story is the quarter-on-quarter momentum: revenue growing 12.1% while PAT crawled forward just 1.4%. That margin compression — roughly 90 basis points — is the tension that defines the quarter and explains why the market punished the stock 14% despite what looked like blowout numbers.
What the divergence reveals: raw material lag is biting
Management claimed "100% raw material and forex pass-through" to customers, but the P&L tells a different story. Cost of goods sold, as a percentage of revenue, rose sequentially: 20% (Q3 FY26) → 24% (Q4) → 28% (Q1 FY27). That 8-percentage-point drift in a single quarter is material. On the call, management acknowledged the lag explicitly: raw material cost increases take 2–3 months to flow through to customers via quarterly business reviews (QBRs). In the interim, Omnitech absorbs the margin hit. This is not a crisis — long-term contracts and pass-through clauses are real — but it explains why PAT growth (1.4% QoQ) lags revenue growth (12.1%). The gap will narrow as price increases propagate, but near-term earnings are volatile.
61.5% YoY revenue growth, PAT surged
₹166.7 Cr revenue, ₹29.7 Cr PAT, but QoQ only +12.1% rev and +1.4% PAT
Supported (headline), but prior year was depressed; organic growth is slower
35–40% FY27–FY28 guidance (raised from 30–35%)
Q1 was 61.5% YoY vs. weak base; full-year guided 35–40%, implying moderation
Supported; guidance raised but modestly; normalized run-rate ~35–40%
Robust ₹3,000 Cr order book, 3–5 year visibility
Confirmed: ₹2,000 Cr multi-year oil/gas (3–5 yr), ₹1,000 Cr short/medium (6–18 mo)
Supported, but 67% concentrated in two anchors (oil/gas)
100% raw material and forex pass-through
COGS % rose 20%→28% QoQ; 2–3 month lag acknowledged; currency pass-through also lagged
Overstated; true long-term but operationally misleading short-term
Working capital improved meaningfully to 233 days from 294
Confirmed: inventory 225→182 days, receivables 153→119, payables 80→69
Supported; execution solid; target further 10–20% improvement
What changed on this call
Growth guidance raised 30–35% → 35–40% (modest upgrade for FY27–FY28)
Capex accelerated: ₹250 Cr over 14 months (₹100 Cr building, ₹150 Cr plant/machinery)
Machine capacity +30% (42–43 lakh hours post-ramp); FY28 commissioning
Defense/aerospace now in first-article (FA) and Nadcap certification phases; 1–3 year ramp
Working capital discipline demonstrated: 61-day improvement; further 10–20% target
Margin outlook stable, not expanding: EBITDA 30%+, gross 68–71%, reflecting raw material lag
Order book visibility: ₹3,000 Cr, 3–5 years out, anchored by Weatherford and oil/gas majors
Capex-backed capacity adds 30% machine hours; targets ₹1,600+ Cr revenue potential post-ramp
Working capital discipline: 61-day improvement YoY, target further 10–20% (cash generation tailwind)
Geographic diversification underway: North America 52% rebalancing toward Europe/Middle East (10–20% target)
Q1 headline 61% growth is inflated by depressed prior-year base; organic QoQ momentum is slower (12% rev, 1.4% PAT)
Raw material cost lag (2–3 months) is squeezing margins QoQ; COGS % rose 20%→28% despite pass-through claims
Customer concentration: ₹2,000 Cr of ₹3,000 Cr (67%) in two oil/gas anchors; trials with 3–4 majors underway (6–12 mo timeline)
Capex execution delayed (1–1.5 months behind schedule due to rains); utilization ramp unproven
Defense/aerospace entry is speculative: <1% of revenue, 1–3 year ramp, no quantified order pipeline
Risks, ranked by holder concern
Customer concentration (₹2,000 Cr / ₹3,000 Cr = 67% in two oil/gas anchors)
HighWeatherford + one unnamed large customer dominate the order book. Loss of either (e.g., cyclical pullback, competitive loss) would materially compress revenue visibility. Mitigation: trials with ABB, Siemens, Oshkosh, BLY underway; 6–12 month approval timeline.
Raw material cost lag (2–3 months pass-through via QBRs)
HighCOGS % of revenue rose 20%→28% QoQ despite claimed 100% pass-through. This creates quarterly earnings volatility and margin compression until customers reprice. Mitigation: long-term contracts with pass-through clauses; currency hedges in place; lag should normalize over time.
Capex execution and utilization (₹250 Cr for +30% capacity)
MediumNew facilities start FY28, already 1–1.5 months behind schedule. If order book doesn't grow proportionally, utilization and ROCE could suffer. Mitigation: ₹3,000 Cr order book provides buffer; management disciplined on capex pacing; phased machinery deployment.
Defense/aerospace ramp timing (1–3 years, currently <1% revenue)
MediumEntry is real (FA approvals, Nadcap certification in progress), but revenue contribution is speculative. Framed as 'very good vertical' but no quantified order pipeline or timeline. Mitigation: multiple Tier-1 OEM trials ongoing; capability already exists (precision to 5 microns).
Geographic concentration (North America 52%, oil/gas exposed)
MediumDownturn in US shale/energy cycle could compress order flow and utilization. Rebalancing to Europe/Middle East is underway (10–20% target) but slow. Mitigation: broad customer base (256+ customers across 24 countries); emerging regions growing.
How the street is positioned
The market's -14.41% sell-off on day 1 (₹732.6 → ₹578.35) is the street's own verdict on earnings quality. Stock is now 24% below its all-time high of ₹762.7 but still +228% above the 52-week low of ₹176.25, reflecting the prior run-up from the IPO narrative. Critically, institutional positioning is stable: FII ownership flat at 4.31% (up 5 bps), DII trimmed to 10.81% (down 112 bps), promoter steady at 74.19%. The lack of panic FII selling suggests large institutions are not bailing, but the retail/momentum crowd clearly took the headline-misses-organic-growth signal and exited. Volume is increasing, a sign of distribution. The stock's trend remains bullish on the longer chart, but the sharp post-result selloff shows the market is rightfully skeptical: a quarter that looked great in headlines but shows margin compression and slowing organic momentum is not worth holding at an all-time-high valuation.
1 · Q2 QoQ growth trajectory
Does revenue growth accelerate or plateau? Critically, does PAT grow faster than the 1.4% QoQ pace? If margin compression persists, it signals the raw material lag is not normalizing. Watch for any commentary on pricing resets or contract renewals.
2 · Capex ramp and new facility commissioning (H1 FY28)
Does Chhapara's new facility come online on time (already 1–1.5 months delayed)? What are the first-quarter utilization rates? Hitting 35–40% full-year growth guidance will require the new capacity to absorb incremental demand. Miss here and ROCE assumptions crumble.
3 · Customer diversification trials (6–12 month cycle)
Do the motion-control/automation trials with ABB, Siemens, Oshkosh, BLY convert to orders? This is the key to de-risking the oil/gas concentration (67% of order book). If large assembly-side orders win approvals, incremental revenue and margin expansion could follow.
4 · Defense/aerospace FA approvals and Nadcap progress
Any material order wins or customer commitments? This vertical is speculative today but could be a needle-mover if 1–3 year ramp accelerates faster than guided.
Omnitech is a solid execution story with real scaffolding: an order book, disciplined capex, and emerging high-margin verticals. But this quarter is a reminder that headlines can mask softer organic momentum. A 61% YoY surge built on a depressed prior base, paired with a 1.4% QoQ PAT growth, is not the picture of acceleration. Raw material cost lag is squeezing margins today, and until the 2–3 month pass-through cycle normalizes, earnings will remain volatile. The market's 14% selloff is justified.
For holders, the question is whether the order book and capex ramp justify near-term margin pressure. For entry points, wait for evidence that organic QoQ growth is re-accelerating and margin pressure is lifting. The number to track is quarterly PAT growth, not revenue.
Omnitech Q1 FY27: consolidated PAT jumps YoY on revenue beat, OPM slips 3pp QoQ
PAT +468.7% YoY · revenue +61.49% · margins expanding
₹166.66 Cr
+61.49% YoY
₹29.73 Cr
+468.7% YoY
17.24%
₹2.4
Omnitech Engineering's consolidated PAT for Q1 FY27 came in at ₹29.73 Cr on revenue of ₹166.66 Cr, up 61.5% YoY on revenue and roughly 468.7% YoY on PAT (about 359.5% on an adjusted basis excluding this quarter's one-time depreciation-method benefit) against the year-ago quarter's ₹103.21 Cr revenue and ₹5.23 Cr PAT. That June-2025 quarter, however, was the company's first-ever result filed under Regulation 33 following its March 2026 IPO and was unaudited with an unusually thin 7.3% PBT margin, so the scale of the YoY jump partly reflects a soft base rather than a step-change in run-rate. Against management's own FY27 guidance of 30-35% YoY revenue growth (given at the May 2026 Q4 concall), Q1's 61.5% print is comfortably ahead — a beat on the topline metric the company itself set. No third-party analyst estimates for this quarter could be located, so the print cannot be benchmarked against Street consensus; vsStreet is marked unknown rather than assumed.
Q1 FY-2027 vs prior quarters
No year-ago quarter on record — YoY cells may be blank.
The profitability picture is more mixed than the YoY headline suggests. Operating margin (EBITDA/revenue) eased to 30.37% from 33.46% in Q4 FY26 and net margin to 17.24% from 18.24% — a QoQ compression that runs counter to management's stated expectation that the "temporary" Q4 FY26 margin squeeze from pre-emptive capacity and talent investment would revert toward historical levels in FY27; instead it slipped further. The compression traces largely to working-capital timing: the P&L absorbed a bigger share of production cost this quarter, since inventory build added back only ₹131.75 Cr versus ₹321.55 Cr in Q4 FY26, alongside an 8% QoQ rise in employee costs and a 13% QoQ rise in other expenses. Separately, the company switched its depreciation method from written-down-value to straight-line this quarter, a change in accounting estimate under Ind AS 8 that cut depreciation and lifted consolidated PBT by ₹7.6 Cr to ₹39.68 Cr (versus a WDV-equivalent ₹32.07 Cr) — a one-time accounting tailwind layered on top of, not offsetting, the QoQ operating softness.
The stock went into the print at ₹606.75, up 20.5% over the past month of trading.
What the summary numbers don't show
EPS (basic) ₹2.40 for the quarter, down from ₹2.65 in Q4 FY26 despite similar absolute PAT, reflecting a fuller quarter on the post-IPO expanded share base (paid-up capital steady at ₹61.83 Cr).
Management projects continued robust growth in FY27, anticipating a 30-35% year-on-year expansion, consistent with historical trends. While Q4 FY26 saw a temporary margin compression due to pre-emptive investments in capacity and talent for future growth, margins are expected to revert to historical levels. The company
— This quarter: beat
No standalone management commentary or press release accompanied this filing beyond the SEBI-mandated results and auditor review reports, so there is no fresh company framing to reconcile against the numbers. The quarter's other disclosed item was the IPO-proceeds utilisation report: of the ₹3,932.44 Cr net IPO proceeds, ₹2,408.47 Cr remains unutilised as of June 30, 2026, earmarked for the Hyderabad and Chhapara capacity expansions and solar roofing management cited as FY27 growth drivers at the last concall — utilisation of that balance, and whether it lifts run-rate revenue, is the natural next checkpoint. Standalone and consolidated PAT track closely this quarter (₹29.41 Cr vs ₹29.73 Cr, about 1% apart), so the two bases tell a consistent story.
W1
OPM recovery: whether Q2 FY27 operating margin rebounds toward Q4 FY26's 33.46% level as management's promised reversion, after slipping to 30.37% this quarter.
W2
Revenue growth cadence versus the 30-35% YoY FY27 guidance band — Q1's 61.5% YoY print is well ahead; watch whether growth normalizes toward the band or stays elevated.
W3
Utilisation of the ₹2,408.47 Cr unutilised IPO proceeds toward the Hyderabad/Chhapara facilities and solar roofing, and its revenue contribution once commissioned.
Strong Q1 execution meets claims; guidance raised modestly
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 7/10
Grade A
Q1 numbers matched guided range, prior guidance (30-35% FY27 growth) being revised upward to 35-40%, working capital levers executed as promised.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered 61.5% YoY growth with disciplined execution: order visibility (₹3,000 Cr, 3-5 years), margin hold (30.4% EBITDA), working capital win (233 days). Guidance raised to 35-40% from 30-35%. Key risk: QoQ momentum soft (PAT +1.4%), suggesting near-term moderation; defense/aerospace speculative (1-3 years).
₹166.7 Cr
Revenue · +61.5% YoY₹29.7 Cr
Reported PAT · +468.7% YoYFlat
Margins · vs guidance: CorroboratedDid the claims hold up?
61.5% YoY revenue growth, PAT grew significantly
MET₹166.6 Cr revenue (61.5% YoY), ₹29.7 Cr PAT (468.7% YoY EBITDA 90.8%)
35-40% FY27-FY28 growth guidance (raised from 30-35%)
METQ1 delivered 61.5% YoY, but management expects QoQ moderate growth due to prior-year Chhapara ramp-up normalizing
Robust order book over ₹3,000 Cr with 3-5 year visibility
MET₹3,000 Cr confirmed: ₹2,000 Cr multi-year oil/gas (3-5 years), ₹1,000 Cr short/medium cycle (6-18 months)
100% raw material and forex pass-through to customers
OVERSTATEDRaw material costs rose 20%→24%→28% QoQ; pass-through lag is 2-3 months via QBRs. Currency pass-through also present.
Working capital improved meaningfully to 233 days from 294 days
METConfirmed: inventory 225→182 days, receivables 153→119 days, payables 80→69 days
Earnings quality
What changed since the last call
Growth guidance raised 30-35% → 35-40%
UpgradePrior FY-2026 call: 30-35% FY27 expansion. Current: 35-40% range for FY27-FY28, implying modest but real upgrade vs. initial target.
Capex accelerated to ₹250 Cr over 14 months
UpgradeTwo new world-class facilities at Chhapara (₹100 Cr building, ₹150 Cr plant/machinery) will add 10-11 lakh machine hours capacity, enabling ₹1,600+ Cr revenue potential.
Defense/aerospace entered, now in FA phase
NewNadcap certification in progress, Tier-1 OEM trials underway, small revenue (6.9% of 'others' segment) already booked. 1-3 year horizon to material scale.
Working capital discipline demonstrated
UpgradeNWC days improved 294→233 (inventory, receivables normalized post-year-end). Target further 10-20% improvement while scaling revenue.
Margin outlook stable, not expanding
NeutralEBITDA margin 30.4% delivered; guidance 30%+ with gross margin 68-71% (vs. currently ~70%). No expansion, reflecting raw material lag and investment in new verticals.
The Q&A
Moderate pressure on raw material cost lag (20%→28% sequential rise questioned), guidance conservatism (61.5% Q1 vs. 35-40% full-year), and customer concentration (2 oil/gas anchors = ₹2,000 Cr of ₹3,000 Cr book). Management held firm on 2-3 month pass-through lag and explained growth normalization.
Capex, capacity roadmap — Harshit Patel, Equirus Securities
AnsweredMetoda 11 lakh, Chhapara 19.5 lakh, Padavala 1.37 lakh hours currently. ₹250 Cr capex (₹100 Cr building, ₹150 Cr machinery); ₹25 Cr for existing Chhapara, rest for new. Post-ramp: 42-43 lakh hours total.
Defense/aerospace margins, timeline — Harshit Patel, Equirus Securities
PartialMargins better than current business; not subject of discussion. On track for FA approvals, Nadcap accreditation in progress. Multi-year process, 1-3 years for material contribution.
Multi-year order execution, ramp — Lucky Agarwal, Individual
AnsweredOrder is 3-5 year range, different product lines. ~₹50 Cr+ executed Q1. Year-1 to year-5 staggered ramp due to mix with short-cycle orders (3-4 month cycles).
Margin sustainability and guidance — Lucky Agarwal, Individual
AnsweredHistorically 30%+ EBITDA. Capability/competency driven, not segment-specific. Currently investing heavily in new verticals (aerospace, defense, energy). 1-2% variance normal.
FY28 revenue, margin outlook — Deeya Jain, Sapphire Capital
AnsweredHistorically growing 35-40%, projecting same range. Margins 30%+ similar level. Current order book ₹3,000 Cr, ₹166 Cr executed Q1, incoming orders replacing it.
Raw material cost pass-through lag — Sumit Chopra, Individual
PartialProduct mix effect present (low-volume high-mix). Pass-through via QBR takes 2-3 months. Customers have currency pass-through as well; equalize and discuss actual mechanism.
Guidance vs. delivered (60% growth, 35-40% guided) — Sumit Chopra, Individual
AnsweredGuidance is YoY. Prior year Chhapara was ramping step-by-step. Q1 is high, but moderate QoQ growth expected. Full-year FY27 YoY: 35-40% still applies.
Working capital cycle outlook — Aditya Magar, Elios Financial
AnsweredWC currently in range, working to improve 10-20%. North America 55-60%, Middle East/Europe growing (10-20% rebalancing target) to reduce geo concentration.
Depreciation, debt, interest impact — Jagdish, Individual
AnsweredIPO: paid ₹50 Cr debt, total debt now ₹390 Cr. Restructured NBFC loans for lower interest. Moving depreciation from WDV to straight-line for next 3 years capex (₹250-300 Cr), will boost efficiency.
Defense/aerospace conversion timeline — Jagdish, Individual
PartialSome revenue already booked Q1 (small, in 'others'). More in FY27 and FY28. Pipeline strong, industry demand high, good capacity to execute.
Capex ROI, ROCE assumptions — Aman Vij, Astute
AnsweredAsset turnover 2-2.5x currently. ROCE >20%. At peak, takes years to reach due to ongoing FA costs in P&L, new product dev costs still being absorbed.
Anchor customer trials, large order pipeline — Aman Vij, Astute
AnsweredApart from two large, have Oshkosh, BLY, ABB, Siemens approved. Motion control/automation shorter cycle. Working on large assembly-side orders; loose compound FAs completed, moving to approval. 6-12 or 15 months for approval.
Guidance
FY27-FY28: 35-40% YoY growth (raised from 30-35%)
HighHistorically achieving 35-40% range. Current order book ₹3,000 Cr provides 3-5 year visibility; new capacity ramp starting FY28.
Post-capex peak: ₹800-900 Cr/quarter to ₹1,600+ Cr/quarter
MediumNew capex adds 10-11 lakh hours (42-43 lakh total). Assumes similar material mix and revenue-per-hour metrics. Depends on order book absorption.
EBITDA margin: 30%+ maintained
HighHistorically 30%+; Q1 delivered 30.4%. Disciplined pricing on existing verticals, new verticals (defense/aerospace) have higher margins but ramping slower.
Gross margin: 68-71% range
HighCurrently ~70%. Product mix and raw material pass-through lag (2-3 months) drive 68-71% band. No expansion expected.
₹250 Cr capex, phased over FY27-FY28
High₹100 Cr building, ₹150 Cr plant/machinery. Slight spillover to FY28 due to rains (1-1.5 months). Builds two new Chhapara facilities.
Post-capex: further ₹250-300 Cr potential in next 3 years
MediumLand acquired in Ahmedabad, Hyderabad not yet planned. Phased approach based on segment-wise needs and utilization ramp.
Risks the call surfaced
Customer concentration
HighWeatherford + one other large oil/gas customer = ₹2,000 Cr of ₹3,000 Cr order book (67%). Loss of either could materially impact revenue visibility.
Raw material cost lag
MediumCOGS as % of revenue rose 20%→24%→28% QoQ despite claimed 100% pass-through. 2-3 month lag via quarterly business reviews (QBRs) creates quarterly margin pressure.
Capex execution and utilization
Medium₹250 Cr capex for 10-11 lakh new machine hours capacity adds 30% to current 32 lakh hours. Already 1-1.5 months behind schedule due to rains. If order book doesn't grow proportionally, utilization/ROCE could suffer.
Defense/aerospace ramp timing
MediumDefense/aerospace currently ~0.5% of revenue. FA approvals, Nadcap certification, and order conversions expected 1-3 years out. No material contribution until late FY28-FY29 at earliest.
Geographic concentration
MediumNorth America 52% of revenue, primarily oil/gas. Downturn in US shale/energy could compress order flow and utilization. Rebalancing to Europe/Middle East underway but slow.
Management
Score 7/10. Detailed and specific (machine hour capacity, capex breakdowns, customer names where allowed). Transparent on constraints (2-3 month pass-through lag, 1-1.5 month schedule slippage). Some defensiveness on margin sustainability amid rising costs. Delivered Q1 numbers matching claims precisely (61.5% YoY, 30.4% EBITDA margin, WC improvement). Track record of guidance met on margin discipline and working capital. Modest FY26 guidance (30-35%) been raised to 35-40% for FY27-FY28.
1 · FY28 Q1-Q2
New Chhapara facility ramps; first ₹50+ Cr multi-year order execution
2 · FY28-FY29
Defense/aerospace FA approvals, Nadcap certification; revenue contribution begins
3 · H2 FY27
Motion control/automation customer approvals (6-12 months timing cited)
Key risk: QoQ momentum soft (PAT +1.4%), suggesting near-term moderation; defense/aerospace speculative (1-3 years).